Treace Medical Concepts
TMCI
123 hedge funds and large institutions have $895M invested in Treace Medical Concepts in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 25 reducing their positions, and 14 closing their positions.
671% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $1.97M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
128% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 25
121% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 14
45% more capital invested
Capital invested by funds: $618M → $895M (+$278M)
16% more funds holding
Funds holding: 106 → 123 (+17)
7.02% more ownership
Funds ownership: 51.08% → 58.1% (+7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$25.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$12.7M |
| 4 |
PA
Perceptive Advisors
New York
|
+$11.6M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$9.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$12.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.63M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.83M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$3.22M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$2.85M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCG
126
Lisanti Capital Growth
New York
| – | -$1.43M | -62,405 | Closed |
|
|
LCM
127
Legato Capital Management
San Francisco,
California
| – | -$793K | -34,494 | Closed |
|
|
GIPM
128
G2 Investment Partners Management
New York
| – | -$506K | -22,000 | Closed |
|
129
SG Americas Securities
New York
| – | -$189K | -8,236 | Closed |
|
|
FIM
130
FWL Investment Management
Dallas,
Texas
| – | -$123K | -5,347 | Closed |
|
|
AS
131
Altshuler Shaham
Tel Aviv,
Israel
| – | -$25.2K | -1,097 | Closed |
|
|
QL
132
Quarry LP
New York
| – | -$6.28K | -273 | Closed |
|
|
BAM
133
Belpointe Asset Management
Reno,
Nevada
| – | -$5.88K | -256 | Closed |
|
|
S
134
SignatureFD
Atlanta,
Georgia
| – | -$1.24K | -54 | Closed |
|
|
DFCM
135
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$1.06K | -46 | Closed |
|
|
AF
136
Allworth Financial
Folsom,
California
| – | -$713 | -31 | Closed |
|
TMCI Hedge Fund Activity: Q1 2023 in Review
123 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2023, worth a combined $895M — up 45% from $618M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new TMCI positions and 14 closed out — a net gain of 17 holders — while 57 added to existing stakes and 25 trimmed.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $25.5M. The largest seller was Janus Henderson Group, cutting an estimated $12.6M.
- 123 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2023, up from 106 in Q4 2022.
- Funds reported $895M of Treace Medical Concepts stock for Q1 2023, up 45% quarter-over-quarter.
- 31 funds opened new Treace Medical Concepts positions in Q1 2023 and 14 closed out, a net change of +17 holders.
- The largest Treace Medical Concepts buyer in Q1 2023 was Loomis, Sayles & Company, an estimated $25.5M added.
- The largest Treace Medical Concepts seller in Q1 2023 was Janus Henderson Group, an estimated $12.6M sold.
Based on aggregated 13F filings for Q1 2023.